Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 138 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 128 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 53.9 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 2.0 | BCD100624C013 | - | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 121 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 175 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 177 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 46.8 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 0.0 | BCD100624C001 | 121 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 0.5 | BCD100624C003 | 114 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 1.0 | BCD100624C007 | 55.1 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 2.0 | BCD100624C011 | 95.5 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 4.0 | BCD100624C015 | 72.5 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 8.0 | BCD100624C019 | 107 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 12.0 | BCD100624C023 | 120 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 24.0 | BCD100624C027 | 92.9 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 123 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | - | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 107 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 56.8 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 58.5 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 102 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 54.2 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 0.5 | BCD100624C004 | 134 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 1.0 | BCD100624C008 | 119 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 2.0 | BCD100624C012 | 110 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 4.0 | BCD100624C016 | - | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 8.0 | BCD100624C020 | 88.8 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 12.0 | BCD100624C024 | 39.5 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 24.0 | BCD100624C028 | 167 | pmol/sample |